9N5K image
Deposition Date 2025-02-04
Release Date 2025-10-15
Last Version Date 2025-10-22
Entry Detail
PDB ID:
9N5K
Keywords:
Title:
Endogenous Pfs230D9-14 in complex with Pfs48/45
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
4.70 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Gametocyte surface protein P230
Gene (Uniprot):PFS230
Chain IDs:A
Chain Length:3135
Number of Molecules:1
Biological Source:Plasmodium falciparum 3D7
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Gametocyte surface protein P45/48
Gene (Uniprot):PF45/48
Chain IDs:B (auth: D)
Chain Length:448
Number of Molecules:1
Biological Source:Plasmodium falciparum 3D7
Ligand Molecules
Primary Citation

Abstact

The Pfs230:Pfs48/45 complex forms the basis for leading malaria transmission-blocking vaccine candidates, yet little is known about its molecular assembly. Here, we used cryogenic electron microscopy to elucidate the structure of the endogenous Pfs230:Pfs48/45 complex bound to six potent transmission-blocking antibodies. Pfs230 consists of multiple domain clusters rigidified by interactions mediated through insertion domains. Membrane-anchored Pfs48/45 forms a disc-like structure and interacts with a short C-terminal peptide on Pfs230 that is critical for Pfs230 membrane-retention in vivo. Interestingly, membrane retention through this interaction is not essential for transmission to mosquitoes, suggesting that complex disruption is not a mode of action for transmission-blocking antibodies. Analyses of Pfs48/45- and Pfs230-targeted antibodies identify conserved epitopes on the Pfs230:Pfs48/45 complex and provides a structural paradigm for complement-dependent activity of Pfs230-targeting antibodies. Altogether, the antibody-bound Pfs230:Pfs48/45 structure presented improves our molecular understanding of this biological complex, informing the development of next-generation Plasmodium falciparum transmission-blocking interventions.

Legend

Protein

Chemical

Disease

Primary Citation of related structures